Lang Sheng Investment Group

Lang Sheng Investment Group ("LSI", also known as "Langsheng Investment") is a leading Chinese venture capital/private equity firm founded in Shanghai in 2010 that specializes primarily in early-stage A-B round investments targeting innovative life science/healthcare and technology-driven enterprises. While it does not develop drugs or devices itself, it has backed notable medtech innovators such as Ankon Technologies—the developer of NaviCam magnetically controlled capsule endoscopy system now used clinically across major centers—which exemplifies its focus on disruptive medical technologies within China's rapidly growing health sector ecosystem. The company remains active and independent with no evidence of acquisition or public listing based on available information.[1][2][3][4]